Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mohammad Reza Khirehgesh"'
Autor:
Sajad Fakhri, Seyed Zachariah Moradi, Seyed Yahya Moradi, Sarina Piri, Behrang Shiri Varnamkhasti, Sana Piri, Mohammad Reza Khirehgesh, Ankur Bishayee, Nicolette Casarcia, Anupam Bishayee
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-29 (2024)
Abstract Background Due to the complex pathophysiological mechanisms involved in cancer progression and metastasis, current therapeutic approaches lack efficacy and have significant adverse effects. Therefore, it is essential to establish novel strat
Externí odkaz:
https://doaj.org/article/e6184cf391574394af5d5d12a154c146
Autor:
Ali Moini, Mohammad Reza Khirehgesh, Amir Sarkhosh, Atena Godarzi, Asad Vaisi-Raygani, Amir Kiani
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 21, Iss 2 (2022)
Asthma is a complex disease caused by a combination of multiple genetic and environmental factors. Angiotensin-converting enzyme (ACE) is involved in the pathogenesis of asthma by inactivating bradykinin, substance P, and neurokinin A. It has been sh
Externí odkaz:
https://doaj.org/article/6aff1f59414540a1bd65e63691cde19a
Autor:
Ali Moini, Mohammad Reza Khirehgesh, Amir Sarkhosh, Atena Godarzi, Asad Vaisi-Raygani, Amir Kiani
Publikováno v:
Iranian journal of allergy, asthma, and immunology. 21(2)
Asthma is a complex disease caused by a combination of multiple genetic and environmental factors. Angiotensin-converting enzyme (ACE) is involved in the pathogenesis of asthma by inactivating bradykinin, substance P, and neurokinin A. It has been sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5934db31a7887d38c048aca83b1be74
https://pubmed.ncbi.nlm.nih.gov/35490264
https://pubmed.ncbi.nlm.nih.gov/35490264
Publikováno v:
Molecular biotechnology. 63(6)
Targeted therapy is an effective and appropriate approach with low side effects in cancer therapy compared with other treatment approaches. Epidermal growth factor receptor, EGFR, is a favorable biomarker as targeted therapy because it overexpresses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdcdb13271ee1ed1c1e6375153410cbb
https://pubmed.ncbi.nlm.nih.gov/33772436
https://pubmed.ncbi.nlm.nih.gov/33772436
Publikováno v:
Journal of drug targeting. 29(4)
Targeted therapy is one of the favourable methods used in cancer treatment. Several recombinant proteins and small-molecules used for this aim include monoclonal antibodies, antibody fragments and peptides. Nanobody (Nb) is a camelid antibody fragmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091b970b57de3221b0f5ec6f90703f18
https://pubmed.ncbi.nlm.nih.gov/33210573
https://pubmed.ncbi.nlm.nih.gov/33210573
Autor:
Mohammad Reza Khirehgesh, Kheirollah Yari, Bahman Akbari, Jafar Sharifi, Kamran Mansouri, Bijan Soleymani, Fatemeh Safari
Publikováno v:
Journal of Drug Delivery Science and Technology. 66:102837
Targeted therapy has been developed for increasing the efficacy of cancer treatment. The first step in targeted therapy is to select the appropriate cell surface marker as targeting. Epidermal growth factor receptor (EGFR) is one of the tumor cell su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4068ad9777df37b61532848038bcdbe
https://doi.org/10.1016/j.jddst.2021.102837
https://doi.org/10.1016/j.jddst.2021.102837